84 reports

  • 1.2 Types of PAP
  • 1.1 Pulmonary Alveolar Proteinosis (PAP)

Hereditary PAP is a genetic disorder which is determined by inheritance of traits from parents.

  • Respiratory Disease
  • Therapy
  • World
  • Market Size
  • Mast Therapeutics, Inc.
  • DAVIES J, ET AL. (2007). CYSTIC FIBROSIS. BMJ; 335
  • 2.1 THERAPY AREA INTRODUCTION

CYSTIC FIBROSIS GENETIC ANALYSIS CONSORTIUM.

  • Respiratory Disease
  • World
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC

The burden of chronic obstructive pulmonary disease (COPD) across the globe is high due to risk factors such as biomass fuel use, genetic susceptibility, and tobacco smoking.

  • Respiratory Disease
  • Boston Scientific Corporation
  • Broncus Medical Inc.
  • Medtronic, Inc.
  • Olympus Corporation
  • THE PATHOGENESIS OF COPD
  • 5.2 RISK FACTORS AND COMORBIDITIES

TO A LESSER EXTENT, GENETIC RISK FACTORS ALSO CONTRIBUTE TO THE DEVELOPMENT OF COPD.

  • Respiratory Disease
  • Demand
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.
  • GLOBAL ASTHMA OXYGEN THERAPY EQUIPMENT
  • TH RAPY EQUIPMENT M RK T

GENETIC PREDISPOSITION AS WELL AS RAPIDLY GROWING AIR POLLUTION HAS BEEN TRIGGERING THE UPSURGE OF ACUTE ASTHMA.

  • Respiratory Disease
  • World
  • Inogen, Inc.
  • Invacare Corporation
  • Philips Respironics, Inc.
  • Increasing prevalence of allergic rhinitis and asthma coupled with high consumption of tobacco

Prevalence of allergic rhinitis and asthma Impact of tobacco consumption These conditions occur due to genetic factors and lifestyle changes such as vehicular pollution and exposure to animals/ pets.

  • Respiratory Disease
  • Market Size
  • Allergy Therapeutics plc
  • Merck & Co., Inc.
  • Stallergenes SA

Genetically Modified Rice as Immunotherapy ##. ##. ## Effects of the Rising Levels of Generic Drug Penetration ##. ##. ## Japan Allergic Rhinitis Drugs Market: Market Forecast 2016-2027 ##. ## Russia ##. ##. ## How Will Russia’s Economic Status Affect Its Pharma Industry?

  • Allergy Drug
  • OTC
  • Respiratory Disease
  • World
  • Forecast
  • MARKET OUTLINE

Genetic factors: Alpha-## antitrypsin deficiency is also believed to play a role in the development of COPD; but it is exquisite.

  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • EMPHYSEMA GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • 5.4.2 EMPHYSEMA

MANY PHYSICIANS IN ADDITION TO NEW BORN SCREENING OR GENETIC TESTING RELY ON SPIROMETERS FOR THE EARLY DIAGNOSIS.

  • Respiratory Disease
  • World
  • Market Size
  • Medtronic, Inc.
  • ResMed Inc.
  • Identifying factors impacting market growth

In addition to genetic factors, lifestyle factors also influence the prevalence of allergic rhinitis.

  • Respiratory Disease
  • World
  • Forecast
  • GlaxoSmithKline plc
  • Sanofi S.A.

A nasal cannula is mainly used for the treatment of the following disorders: Asthma: It is the most common pulmonary disease in children and adults, which can be genetic or acquired due to lifestyle changes.

  • Respiratory Device
  • Respiratory Disease
  • World
  • Forecast
  • Teleflex Incorporated
  • Market drivers
  • INCREASED PREVALENCE OF ALLERGIC RHINITIS

The condition occurs due to genetic factors and or an increase in exposure to vehicular pollution, animal dander, or pollen.

  • Allergy Drug
  • Respiratory Disease
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Strength
  • Market drivers

Genetic factors are thought to play a significant role in disease management.

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

Hereditary deficiency of alpha-## antitrypsin is the major genetic risk factor for COPD and provides a model for how other genetic risk factors are thought to contribute to the disease.

  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • Market challenges
  • Market drivers

The above conditions occur due to genetic factors and lifestyle factors such as vehicular pollution and exposure to animals or pets.

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG

Cystic fibrosis (CF) is a type of genetic disorder that affects the body' s exocrine glands which secrete saliva, mucus, tears and sweats.

  • Respiratory Disease
  • World
  • Market Size
  • Astra Group
  • Becton Property Group
  • RISK FACTORS FOR COPD THAT HAVE A ROLE DURING DIFFERENT STAGES OF LIFE
  • RISK FACTORS FOR COPD THAT HAVE A ROLE DURING DIFFERENT STAGES OF LIFE

The mechanisms that predispose COPD patients to lung cancer are not yet fully elucidated, but there are currently two main hypotheses: shared genetic links that predispose to both diseases, and chronic inflammation (Cavaillès et al., 2013).

  • Respiratory Disease
  • Asia
  • Europe
  • Japan
  • World

Genetically Modified Rice as Immunotherapy ##. ##. ## Effects of the Rising Levels of Generic Drug Penetration ##. ##. ## Japanese Allergic Rhinitis Drugs Market: Market Forecast 2016-2026 ##. ## Russia ##. ##. ## How Will Russia’s Economic Status Affect Its Pharma Industry?

  • Allergy Drug
  • OTC
  • Respiratory Disease
  • World
  • Forecast
  • Asthma Therapeutics Market, Asia-Pacific, Market Size ($bn), 2016-2023
  • 6 Multi-Scenario Forecast

Research has highlighted numerous potential causes, the majority of which can be classed as either genetic or environmental.

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • 1.4 TREATMENT OPTIONS FOR ASTHMA

The main cause of COPD is smoking, with scarcer causes including air pollution and genetic disorders.

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • 4.2 EPIDEMIOLOGY

Research has highlighted numerous potential causes, the majority of which can be classed as either genetic or environmental.

  • Respiratory Disease
  • World
  • Almirall, S.A.
  • Genentech, Inc.
  • Novartis AG
  • Long duration of asthma
  • Comorbidities

AAT deficiency is the most well-known genetic factor for COPD, affecting between ##% and ##% of COPD patients.

  • Respiratory Disease
  • Europe
  • World
  • Forecast
  • Social Conditions
  • ASTRAZENECA: US REVENUE OF KEY ASTHMA DRUGS 2011-2014 ($ MILLIONS)
  • 17. Market Growth Drivers

Genetic factors are thought to play a significant role in disease management.

  • Respiratory Disease
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • REFERENCES

A meta-analysis of Th## pathway genetic variants and risk for allergic rhinitis.

  • Allergy Drug
  • Chronic Disease
  • OTC
  • Respiratory Disease
  • Europe
  • CAUSE OF THE DISEASE
  • Clinical phenotypes of asthma using cluster analysis

Genetic heterogeneity of asthma phenotypes identified by a clustering approach.

  • Asthma
  • Chronic Disease
  • Pathology
  • Respiratory Disease
  • Europe

Asthma & COPD are chronic respiratory diseases that are either genetically acquired or caused due to several environmental factors.

  • Air Way Device
  • Asthma
  • Respiratory Device
  • Respiratory Disease
  • North America
  • MONOCLONAL ANTIBODIES TO INHIBIT UPA FOR ACUTE LUNG INJURY,ACUTE RESPIRATORY DISTRESS SYNDROME AND SEPSIS - DRUG PROFILE

Recomodulin is a thrombomodulin agent manufactured using genetic recombination technology.

  • Monoclonal Antibody
  • Respiratory Disease
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company
  • BIOMAY AG

Genetic Immunity is headquartered in Budapest, Hungary.

  • Respiratory Disease
  • Europe
  • United States
  • World
  • Product Initiative
  • Infectious Disease
  • Respiratory Disease
  • United States
  • World
  • Product Initiative
  • Infectious Disease
  • Respiratory Disease
  • United States
  • World
  • Product Initiative